Altria reported adjusted EPS of $1.30 for the fourth quarter, missing the consensus estimate of $1.32 and down slightly from $1.29 a year earlier. Excluding excise taxes, revenue came in at $5.08 billion, modestly above the Wall Street projection of $5.02 billion. Despite top-line outperformance, the earnings shortfall prompted a 5% slide in the stock price on the day of the release, underscoring investor sensitivity to profit metrics in a low-growth sector.

The company’s flagship Marlboro franchise saw premium cigarette volumes plunge 12.6% year-over-year in Q4, outpacing the industry-wide decline. Total cigarette shipments fell by 10%, while Marlboro’s share of the overall U.S. cigarette market contracted by 1.5 percentage points to 39.8%. In the smokeless segment, the on! nicotine pouch brand lost 5.3 points of market share, reflecting intensifying competition and insufficient offset from newer smoke-free offerings.

Altria’s pricing strategy helped it achieve an all-time high adjusted operating margin, benefiting from manageable price elasticity despite lower shipment volumes. The company forecasts full-year 2026 adjusted profit above analysts’ expectations, driven by additional price increases on both cigarettes and oral tobacco products. Marlboro retained a dominant 59.2% share of the premium segment, supporting robust cash flow generation for shareholder returns.